Ccs Associates, INC.

UEI VCNRS52G5PG7 · CA · SAM.gov record ↗

$4.6M

FY2025 obligations

Contract awards

Sep 21, 2017

First action

Jun 10, 2026

Latest action

Obligations by agency

Department Of Health And Human Services$4.6M

Obligations by NAICS

Monthly obligations

Oct 24

Nov 24

Jan 25

Feb 25

Mar 25

May 25

Jun 25

Jul 25

Aug 25

Sep 25

Dec 25

Mar 26

Apr 26

May 26

Jun 26

Contracts ending within 18 months (recompete watch)

75N95023P00808 ↗$128K
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Ends
Sep 12, 2026
Started
Sep 13, 2023
Agency
National Institutes Of Health
NAICS
541990
75N95023P00692 ↗$3K
MEDICAL WRITING CONSULTING SERVICES
Ends
Sep 12, 2026
Started
Sep 13, 2023
Agency
National Institutes Of Health
NAICS
541690
75F40121C00165 ↗$0
THE CONTRACTOR SHALL PROVIDE THE FOLLOWING TASKS/DELIVERABLES OVER THE COURSE OF THE CONTRACT.
Ends
Sep 28, 2026
Started
Sep 1, 2021
Agency
Food And Drug Administration
NAICS
541690
75N91023C00054 ↗$3.1M
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL
Ends
Sep 28, 2026
Started
Sep 29, 2023
Agency
National Institutes Of Health
NAICS
541690
75N91023C00055 ↗$633K
THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE
Ends
Sep 28, 2026
Started
Sep 29, 2023
Agency
National Institutes Of Health
NAICS
541690
75N95026F00001 ↗$210K
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027
Ends
Mar 25, 2027
Started
Mar 26, 2026
Agency
National Institutes Of Health
NAICS
541690

PIID	Description	Agency	NAICS	Obligated	Start	End
75N95023P00808 ↗	REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES	National Institutes Of Health	541990	$128K	Sep 13, 2023	Sep 12, 2026
75N95023P00692 ↗	MEDICAL WRITING CONSULTING SERVICES	National Institutes Of Health	541690	$3K	Sep 13, 2023	Sep 12, 2026
75F40121C00165 ↗	THE CONTRACTOR SHALL PROVIDE THE FOLLOWING TASKS/DELIVERABLES OVER THE COURSE OF THE CONTRACT.	Food And Drug Administration	541690	$0	Sep 1, 2021	Sep 28, 2026
75N91023C00054 ↗	THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL	National Institutes Of Health	541690	$3.1M	Sep 29, 2023	Sep 28, 2026
75N91023C00055 ↗	THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE	National Institutes Of Health	541690	$633K	Sep 29, 2023	Sep 28, 2026
75N95026F00001 ↗	REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027	National Institutes Of Health	541690	$210K	Mar 26, 2026	Mar 25, 2027

Largest awards

75N91023C00054 ↗$3.1M
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL
Ends
Sep 28, 2026
Started
Sep 29, 2023
Agency
National Institutes Of Health
NAICS
541690
75N91023C00055 ↗$633K
THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE
Ends
Sep 28, 2026
Started
Sep 29, 2023
Agency
National Institutes Of Health
NAICS
541690
75N95025F00001 ↗$395K
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. APRIL 1, 2025 TO MARCH 31, 2026
Ends
Mar 30, 2026
Started
Mar 31, 2025
Agency
National Institutes Of Health
NAICS
541690
75N95025F00001 ↗$231K
NEW SOW FOR REGULATORY ACTIVITIES FOR PCCA AND MMAB GENE THERAPY PRODUCTS
Ends
May 19, 2028
Started
May 20, 2025
Agency
National Institutes Of Health
NAICS
541690
75N95026F00001 ↗$210K
REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027
Ends
Mar 25, 2027
Started
Mar 26, 2026
Agency
National Institutes Of Health
NAICS
541690
75N95023P00808 ↗$128K
REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES
Ends
Sep 12, 2026
Started
Sep 13, 2023
Agency
National Institutes Of Health
NAICS
541990
75N95024F00001 ↗$94K
REGULATORY AFFAIRS SUPPORT. CCS ASSOCIATES, INC. N01DA-23-8933. APRIL 1, 2024 TO MARCH 31, 2025
Ends
Mar 30, 2025
Started
Mar 31, 2024
Agency
National Institutes Of Health
NAICS
541690
75N95023P00692 ↗$3K
MEDICAL WRITING CONSULTING SERVICES
Ends
Sep 12, 2026
Started
Sep 13, 2023
Agency
National Institutes Of Health
NAICS
541690
75N93021D00040 ↗$0
THE PURPOSE OF THIS MODIFICATION IS TO REVISE SECTION J. LIST OF ATTACHMENTS, ITEM 1. STATEMENT OF WORK. THE REVISION REMOVES LANGUAGE LIMITING SUPPORT TO THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) AND EXPANDS THE SCOPE OF THE
Ends
—
Started
Aug 31, 2021
Agency
National Institutes Of Health
NAICS
541714
75F40121C00165 ↗$0
THE CONTRACTOR SHALL PROVIDE THE FOLLOWING TASKS/DELIVERABLES OVER THE COURSE OF THE CONTRACT.
Ends
Sep 28, 2026
Started
Sep 1, 2021
Agency
Food And Drug Administration
NAICS
541690
75N95022F00002 ↗$-281
FY26 UDO INITIATIVE REGULATORY SUPPORT FOR PREPARATION AND FILING OF A PRE-INVESTIGATIONAL NEW DRUG (PRE-IND) APPLICATION WITH THE FOOD AND DRUG ADMINISTRATION (FDA) FOR CLINICAL DEVELOPMENT OF MITRAGYNINE (MG).
Ends
Dec 30, 2023
Started
Sep 21, 2022
Agency
National Institutes Of Health
NAICS
541690
75N95022F00001 ↗$-1K
FY26 UDO INITIATIVE PREPARATION OF AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) FOR A TREATMENT FOR JANSEN'S METAPHYSEAL CHONDRODYSPLASIA
Ends
Jun 8, 2025
Started
Jun 9, 2022
Agency
National Institutes Of Health
NAICS
541690
75N95020P00589 ↗$-2K
FY26 UDO INITIATIVE MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES
Ends
Sep 12, 2023
Started
Sep 10, 2020
Agency
National Institutes Of Health
NAICS
541990
75N91018C00030 ↗$-2K
TECHNICAL INFORMATION RESEARCH FOR CANCER PREVENTIVE AGENT DEVELOPMENT. PERIOD OF PERFORMANCE: 09/30/2022 - 09/29/2023
Ends
Sep 28, 2023
Started
Sep 29, 2018
Agency
National Institutes Of Health
NAICS
541690
75N93024F00001 ↗$-29K
TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE TASK ORDER.
Ends
Apr 29, 2024
Started
Nov 14, 2023
Agency
National Institutes Of Health
NAICS
541714
75N91018C00017 ↗$-37K
REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT
Ends
Sep 28, 2023
Started
Sep 29, 2018
Agency
National Institutes Of Health
NAICS
541690
HHSN271201700070C ↗$-193K
REGULATORY AFFAIRS SUPPORT
Ends
Sep 18, 2023
Started
Sep 21, 2017
Agency
National Institutes Of Health
NAICS
541990

PIID	Description	Agency	NAICS	Obligated	Start	End
75N91023C00054 ↗	THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING REQUIREMENT FOR REGULATORY SERVICES AND TECHNICAL	National Institutes Of Health	541690	$3.1M	Sep 29, 2023	Sep 28, 2026
75N91023C00055 ↗	THE PURPOSE OF THE ACQUISITION IS TO PROVIDE A VARIETY OF CRITICAL CANCER PREVENTION INFORMATION MANAGEMENT FUNCTIONS NECESSARY TO SUPPORT THE IDENTIFICATION, DEVELOPMENT, AND QUALIFICATION OF POTENTIAL CANCER PREVENTIVE AGENTS FOR INVESTIGATIONAL NE	National Institutes Of Health	541690	$633K	Sep 29, 2023	Sep 28, 2026
75N95025F00001 ↗	REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. APRIL 1, 2025 TO MARCH 31, 2026	National Institutes Of Health	541690	$395K	Mar 31, 2025	Mar 30, 2026
75N95025F00001 ↗	NEW SOW FOR REGULATORY ACTIVITIES FOR PCCA AND MMAB GENE THERAPY PRODUCTS	National Institutes Of Health	541690	$231K	May 20, 2025	May 19, 2028
75N95026F00001 ↗	REGULATORY PREPARATION, REVIEW, AND SUBMISSION FOR CLINICAL TRIALS ASSOCIATED WITH NIDA DRUG SUPPLY PROGRAM. N01DA-23-8933. MARCH 27, 2026 TO MARCH 26, 2027	National Institutes Of Health	541690	$210K	Mar 26, 2026	Mar 25, 2027
75N95023P00808 ↗	REGULATORY AFFAIRS CONSULTING SUPPORT SERVICES	National Institutes Of Health	541990	$128K	Sep 13, 2023	Sep 12, 2026
75N95024F00001 ↗	REGULATORY AFFAIRS SUPPORT. CCS ASSOCIATES, INC. N01DA-23-8933. APRIL 1, 2024 TO MARCH 31, 2025	National Institutes Of Health	541690	$94K	Mar 31, 2024	Mar 30, 2025
75N95023P00692 ↗	MEDICAL WRITING CONSULTING SERVICES	National Institutes Of Health	541690	$3K	Sep 13, 2023	Sep 12, 2026
75N93021D00040 ↗	THE PURPOSE OF THIS MODIFICATION IS TO REVISE SECTION J. LIST OF ATTACHMENTS, ITEM 1. STATEMENT OF WORK. THE REVISION REMOVES LANGUAGE LIMITING SUPPORT TO THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) AND EXPANDS THE SCOPE OF THE	National Institutes Of Health	541714	$0	Aug 31, 2021	—
75F40121C00165 ↗	THE CONTRACTOR SHALL PROVIDE THE FOLLOWING TASKS/DELIVERABLES OVER THE COURSE OF THE CONTRACT.	Food And Drug Administration	541690	$0	Sep 1, 2021	Sep 28, 2026
75N95022F00002 ↗	FY26 UDO INITIATIVE REGULATORY SUPPORT FOR PREPARATION AND FILING OF A PRE-INVESTIGATIONAL NEW DRUG (PRE-IND) APPLICATION WITH THE FOOD AND DRUG ADMINISTRATION (FDA) FOR CLINICAL DEVELOPMENT OF MITRAGYNINE (MG).	National Institutes Of Health	541690	$-281	Sep 21, 2022	Dec 30, 2023
75N95022F00001 ↗	FY26 UDO INITIATIVE PREPARATION OF AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) FOR A TREATMENT FOR JANSEN'S METAPHYSEAL CHONDRODYSPLASIA	National Institutes Of Health	541690	$-1K	Jun 9, 2022	Jun 8, 2025
75N95020P00589 ↗	FY26 UDO INITIATIVE MEDICAL WRITING CONSULTING AND DRUG DOSSIER DEVELOPMENT SUPPORT SERVICES	National Institutes Of Health	541990	$-2K	Sep 10, 2020	Sep 12, 2023
75N91018C00030 ↗	TECHNICAL INFORMATION RESEARCH FOR CANCER PREVENTIVE AGENT DEVELOPMENT. PERIOD OF PERFORMANCE: 09/30/2022 - 09/29/2023	National Institutes Of Health	541690	$-2K	Sep 29, 2018	Sep 28, 2023
75N93024F00001 ↗	TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE TASK ORDER.	National Institutes Of Health	541714	$-29K	Nov 14, 2023	Apr 29, 2024
75N91018C00017 ↗	REGULATORY SUPPORT FOR CANCER PREVENTION AGENT DEVELOPMENT	National Institutes Of Health	541690	$-37K	Sep 29, 2018	Sep 28, 2023
HHSN271201700070C ↗	REGULATORY AFFAIRS SUPPORT	National Institutes Of Health	541990	$-193K	Sep 21, 2017	Sep 18, 2023